1.5 Abstract in rivista

1.5 Abstract in rivista: [1866] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1.101 a 1.120 di 1.866

Pancreatic transplant function evaluation by Tc-99m-Sestamibi scintigraphy

1999-01-01 Carmellini, M.; Marchetti, P.; Manca, G.; Aragona, M.; Boggi, U.; Fontanelli, D.; Mosca, F.; Bianchi, R.

Hepatocyte grafting as an alternative to liver transplant

2001-01-01 Carraresi, L.; Mora, M.; Lazzeri, M.; Comporti, M.; Carli, A.; Carmellini, M.; Rossini, M.

Excellent long term results in de-novo renal transplant recipients treated with m-TOR inhibitors, basiliximab and reduced calcineurin inhibitors exposure

2007-01-01 Carmellini, Mario; Collini, A; Ruggieri, Giuliana; Garosi, G; Bernini, M.

Analysis of post-transplant diabetes mellitus (PTDM) prevalence in a population of kidney transplant recipients

2007-01-01 Barni, R; Cataldo, D; Bonato, V; Collini, A; Ruggieri, Giuliana; De Bartolomeis, C; Nigi, L; Bernini, M; Dotta, Francesco; Carmellini, Mario

Post transplant diabetes mellitus: role of insulin-resistance and pro-inflammatory cytokines in first year post-transplant

2008-01-01 Bonato, V; Cataldo, D; Calabrese, M; Tondi, C; Carmellini, Mario; Dotta, Francesco

Conversion of Stable Kidney Transplant Recipients from a Twice-Daily Everolimus Regimen to a Once-Daily Everolimus Regimen.

2009-01-01 Carmellini, Mario; Bernini, M; Ruggieri, Giuliana; Collini, A.

safe conversion of stable kidney transplant recipients from twice-daily tacrolimus (Prograf) to once-daily modified release tacrolimus (advagraf)

2011-01-01 Carmellini, M.; Ruggieri, G.; Collini, A.

Corelation of everolimus exposure with efficacy and safety outcomes in renal transplant recipeints: 24-month update

2011-01-01 Carmellini, M.; Yaqoob, M.; Pattison, J.; Riad, H.; Wang, Z.; Cornu-Artis, C.; Silva, H. T.

Renal function in renal transplant recipients after 24 months of immunosuppression with concentrations-controlled everolimus plus reduced cyclosporine exposure: unpdate from the A2309 study

2011-01-01 Carmellini, M.; Pattison, J.; Riad, H.; Yaqoob, M.; Vergara, M.; Witte, S.; Cibrik, D.

Study Design and Preliminary Results of the Italian Everolimus Registry CERTIC in Kidney Transplant Patients

2012-01-01 Carmellini, Mario; Bertoni, E; Tisone, G.; Cappelli, G.; Colombo, D; Brusa, R; Ponticelli, C.

Exposure-Response Analysis of Everolimus with Reduced Cyclosporine in Renal Transplant Recipients at 24 Months in a Randomized Trial.

2012-01-01 Shihab, F.; Cibrik, D.; Chan, L.; Carmellini, Mario

Turnover and catabolic sites of recombinant human 125-I-Tumor necrosis factor

1986-01-01 Bocci, V.; Pacini, A.; Pessina, G. P.; Maioli, E.; Naldini, A.

Plasma kinetic and catabolic sites of recombinant human tumor necrosis

1987-01-01 Pessina, G. P.; Pacini, A.; Maioli, E.; Naldini, A.; Corradeschi, F.; Nicoletti, C.; Bocci, V.

Plasma kinetics, distribution and fate of tumor necrosis factor

1987-01-01 Pessina, G. P.; Pacini, A.; Maioli, E.; Nicoletti, C.; Naldini, A.; Bocci, V.

Study om plasma tumor necrosis factor (TNF). Kinetics related to route of administration

1987-01-01 Pacini, A.; Maioli, E.; Pessina, G. P.; Naldini, A.; Corradeschi, F.; Nicoletti, C.; Bocci, V.

Administration of interferons and interleukin 2 via the lymphatic route

1988-01-01 Bocci, V.; Ricci, L.; Pessina, G. P.; Nicoletti, C.; Naldini, A.; Carraro, F.

Interferon (IFN) levels in human pulmonary tumors

1989-01-01 Carraro, F.; Borrelli, E.; Naldini, A.; Biagi, G.; Gotti, G.; Giomarelli, P. P.; Bocci, V.

Hypoxia does not affect the antiproliferative activity of interferon "in vitro"

1989-01-01 Naldini, A.; Boscagli, R.; Fedeli, M.; Carraro, F.; Bocci, V.

Fibronectin synthesis: isotpic determination in humans

1989-01-01 Carraro, F.; Naldini, A.; Bocci, V.; Wolfe, R. R.

Estrogen and testosterone change pain incidence and characteristics in MtF and FtM transsexual

2006-01-01 Aloisi, ANNA MARIA; Bacchiocco, V.; Costantino, A.; Stefani, R.; Ceccarelli, Ilaria; Pelusi, G.; Meriggiola, M. C.

Titolo	Data di pubblicazione	Autore(i)	Abstract
Pancreatic transplant function evaluation by Tc-99m-Sestamibi scintigraphy	1-gen-1999	Carmellini, M.; Marchetti, P.; Manca, G.; Aragona, M.; Boggi, U.; Fontanelli, D.; Mosca, F.; Bianchi, R.	-
Hepatocyte grafting as an alternative to liver transplant	1-gen-2001	Carraresi, L.; Mora, M.; Lazzeri, M.; Comporti, M.; Carli, A.; Carmellini, M.; Rossini, M.	-
Excellent long term results in de-novo renal transplant recipients treated with m-TOR inhibitors, basiliximab and reduced calcineurin inhibitors exposure	1-gen-2007	Carmellini, Mario; Collini, A; Ruggieri, Giuliana; Garosi, G; Bernini, M.	-
Analysis of post-transplant diabetes mellitus (PTDM) prevalence in a population of kidney transplant recipients	1-gen-2007	Barni, R; Cataldo, D; Bonato, V; Collini, A; Ruggieri, Giuliana; De Bartolomeis, C; Nigi, L; Bernini, M; Dotta, Francesco; Carmellini, Mario	-
Post transplant diabetes mellitus: role of insulin-resistance and pro-inflammatory cytokines in first year post-transplant	1-gen-2008	Bonato, V; Cataldo, D; Calabrese, M; Tondi, C; Carmellini, Mario; Dotta, Francesco	-
Conversion of Stable Kidney Transplant Recipients from a Twice-Daily Everolimus Regimen to a Once-Daily Everolimus Regimen.	1-gen-2009	Carmellini, Mario; Bernini, M; Ruggieri, Giuliana; Collini, A.	-
safe conversion of stable kidney transplant recipients from twice-daily tacrolimus (Prograf) to once-daily modified release tacrolimus (advagraf)	1-gen-2011	Carmellini, M.; Ruggieri, G.; Collini, A.	-
Corelation of everolimus exposure with efficacy and safety outcomes in renal transplant recipeints: 24-month update	1-gen-2011	Carmellini, M.; Yaqoob, M.; Pattison, J.; Riad, H.; Wang, Z.; Cornu-Artis, C.; Silva, H. T.	-
Renal function in renal transplant recipients after 24 months of immunosuppression with concentrations-controlled everolimus plus reduced cyclosporine exposure: unpdate from the A2309 study	1-gen-2011	Carmellini, M.; Pattison, J.; Riad, H.; Yaqoob, M.; Vergara, M.; Witte, S.; Cibrik, D.	-
Study Design and Preliminary Results of the Italian Everolimus Registry CERTIC in Kidney Transplant Patients	1-gen-2012	Carmellini, Mario; Bertoni, E; Tisone, G.; Cappelli, G.; Colombo, D; Brusa, R; Ponticelli, C.	-
Exposure-Response Analysis of Everolimus with Reduced Cyclosporine in Renal Transplant Recipients at 24 Months in a Randomized Trial.	1-gen-2012	Shihab, F.; Cibrik, D.; Chan, L.; Carmellini, Mario	-
Turnover and catabolic sites of recombinant human 125-I-Tumor necrosis factor	1-gen-1986	Bocci, V.; Pacini, A.; Pessina, G. P.; Maioli, E.; Naldini, A.	-
Plasma kinetic and catabolic sites of recombinant human tumor necrosis	1-gen-1987	Pessina, G. P.; Pacini, A.; Maioli, E.; Naldini, A.; Corradeschi, F.; Nicoletti, C.; Bocci, V.	-
Plasma kinetics, distribution and fate of tumor necrosis factor	1-gen-1987	Pessina, G. P.; Pacini, A.; Maioli, E.; Nicoletti, C.; Naldini, A.; Bocci, V.	-
Study om plasma tumor necrosis factor (TNF). Kinetics related to route of administration	1-gen-1987	Pacini, A.; Maioli, E.; Pessina, G. P.; Naldini, A.; Corradeschi, F.; Nicoletti, C.; Bocci, V.	-
Administration of interferons and interleukin 2 via the lymphatic route	1-gen-1988	Bocci, V.; Ricci, L.; Pessina, G. P.; Nicoletti, C.; Naldini, A.; Carraro, F.	-
Interferon (IFN) levels in human pulmonary tumors	1-gen-1989	Carraro, F.; Borrelli, E.; Naldini, A.; Biagi, G.; Gotti, G.; Giomarelli, P. P.; Bocci, V.	-
Hypoxia does not affect the antiproliferative activity of interferon "in vitro"	1-gen-1989	Naldini, A.; Boscagli, R.; Fedeli, M.; Carraro, F.; Bocci, V.	-
Fibronectin synthesis: isotpic determination in humans	1-gen-1989	Carraro, F.; Naldini, A.; Bocci, V.; Wolfe, R. R.	-
Estrogen and testosterone change pain incidence and characteristics in MtF and FtM transsexual	1-gen-2006	Aloisi, ANNA MARIA; Bacchiocco, V.; Costantino, A.; Stefani, R.; Ceccarelli, Ilaria; Pelusi, G.; Meriggiola, M. C.	-

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1.101 a 1.120 di 1.866

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext1291
reserved465
open93
internalNetwork13
partially open4